CAS 6265-56-1

4-(2-Benzothiazolyl)-1,3-benzenediol

Description:

4-(2-Benzothiazolyl)-1,3-benzenediol, identified by its CAS number 6265-56-1, is an organic compound characterized by its complex aromatic structure. This substance features a benzothiazole moiety, which contributes to its potential biological activity, and a dihydroxybenzene structure, indicating the presence of hydroxyl groups that can participate in hydrogen bonding and influence solubility and reactivity. Typically, compounds of this nature exhibit properties such as moderate to high melting points and may be soluble in organic solvents while showing limited solubility in water due to their hydrophobic aromatic components. The presence of the benzothiazole group often suggests potential applications in pharmaceuticals, dyes, or as intermediates in organic synthesis. Additionally, the compound may exhibit fluorescence or other photophysical properties, making it of interest in materials science and biological imaging. As with many organic compounds, safety and handling precautions should be observed, as they may pose health risks or environmental hazards.

Formula: C₁₃H₉NO₂S

InChI: InChI=1S/C13H9NO2S/c15-8-5-6-9(11(16)7-8)13-14-10-3-1-2-4-12(10)17-13/h1-7,15-16H

InChI key: InChIKey=YQIRLDMXXRINIJ-UHFFFAOYSA-N

SMILES: OC1=C(C2=NC=3C(S2)=CC=CC3)C=CC(O)=C1

Synonyms:

• 4-(2-Benzothiazolyl)-1,3-benzenediol
• 4-(Benzo[d]thiazol-2-yl)benzene-1,3-diol
• 1,3-Benzenediol, 4-(2-benzothiazolyl)-
• Resorcinol, 4-(2-benzothiazolyl)-
• NSC 33005

MHY 553

CAS: 6265-56-1

MHY 553 is a pharmaceutical preparation that contains propranolol hydrochloride. It has been shown to inhibit the growth of human breast cancer cells in culture by lowering camp levels and reducing the number of fatty acids. MHY 553 also inhibits tumor growth in mice with MDA-MB-231 breast cancer and decreases diastolic blood pressure in rats. MHY 553 has been shown to have a protective effect on experimental models of light-induced skin cancer and to bind DNA, inhibiting transcription and replication.

Formula: C₁₃H₉NO₂S

Purity: Min. 95%

Molecular weight: 243.28 g/mol

Ref: 3D-GAA26556

MHY553

CAS: 6265-56-1

MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis.

Formula: C₁₃H₉NO₂S

Color and Shape: Solid

Molecular weight: 243.28

Ref: TM-T68974